European urology oncology

Top Research Topics at European Urology Oncology?

European Urology Oncology focuses largely on the fields of Prostate cancer, Internal medicine, Oncology, Bladder cancer and Radiology. Prostate cancer research presented in it encompasses a variety of subjects, including Magnetic resonance imaging, Biopsy, Prostate and Radiation therapy. The presentations discussing Internal medicine offer insights in topics such as Hazard ratio, Cancer, Confidence interval, Proportional hazards model and Renal cell carcinoma.

The Confidence interval research presented in it explores the relationship between Odds ratio and the closely related topic of Logistic regression. The studies in Renal cell carcinoma featured incorporate elements of Targeted therapy and Nephrectomy. Topics in Oncology were tackled in line with various other fields like Clinical trial, Chemotherapy, Androgen deprivation therapy, Disease and Immunotherapy.

The journal facilitates discussions on Bladder cancer that incorporate concepts from other fields like Stage (cooking) and Urology. The work on Radiology tackled in it brings together disciplines like Multiparametric Magnetic Resonance Imaging and Interquartile range. European Urology Oncology explores issues in Prostatectomy which can be linked to other research areas like Clinical endpoint, Randomized controlled trial, Cohort and Lymph node.

• Prostate cancer (47.88%)
• Internal medicine (46.19%)
• Oncology (38.35%)

What are the most cited papers published in the journal?

• A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer (70 citations)
• Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography (62 citations)
• Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy (57 citations)

Research areas of the most cited articles at European Urology Oncology:

The journal articles aim to foster the development of research in Prostate cancer, Internal medicine, Oncology, Radiology and Cystectomy. The most cited publications hold forums on Prostate cancer that merge themes from other disciplines such as Positron emission tomography, Biopsy and Radiation therapy. The published papers with studies in Oncology featured incorporate elements of Proportional hazards model, Chemotherapy, Docetaxel and Immunotherapy.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Prostate cancer

The previous edition focused in particular on these issues:

The journal was organized to reinforce research efforts on Internal medicine, Prostate cancer, Oncology, Radiology and Bladder cancer. The work tackled in European Urology Oncology goes beyond the discipline of Prostate cancer as it also encompasses Prostate. European Urology Oncology holds forums on Oncology that merges themes from other disciplines such as Systematic review, Enzalutamide, Disease and Genetic testing.

Issues in Radiology were discussed, taking into consideration concepts from other disciplines like Patient summary and Lymph node. It explores research in Urology and overlapping concepts in Urothelial carcinoma to expand the discourse in Bladder cancer. Some problems in Prostatectomy that were presented in European Urology Oncology overlapped with concepts under Randomized controlled trial and Radiation therapy.

The most cited articles from the last journal are:

• Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer (19 citations)
• Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer. (15 citations)
• Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer (14 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in European Urology Oncology (based on the number of publications) are:

• Francesco Montorsi (49 papers) published 17 papers at the last edition, 1 more than at the previous edition,
• Alberto Briganti (42 papers) published 13 papers at the last edition, 1 less than at the previous edition,
• Giorgio Gandaglia (24 papers) published 6 papers at the last edition, 3 less than at the previous edition,
• Shahrokh F. Shariat (21 papers) published 9 papers at the last edition, 7 more than at the previous edition,
• Nicola Fossati (20 papers) published 6 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in European Urology Oncology (based on the number of publications) are:

• Vita-Salute San Raffaele University (73 papers) published 21 papers at the last edition, 3 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (40 papers) published 11 papers at the last edition the same number as at the previous edition,
• Harvard University (34 papers) published 10 papers at the last edition, 1 more than at the previous edition,
• Memorial Sloan Kettering Cancer Center (34 papers) published 8 papers at the last edition, 5 less than at the previous edition,
• Katholieke Universiteit Leuven (28 papers) published 12 papers at the last edition, 6 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.14% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 51.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.95% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.39% of all publications and 20.86% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Prospects and Opportunities in the Field of Urology Oncology

Urology Oncology, an integral sub-discipline within the realm of medical science, brings together a wealth of career prospects and intriguing opportunities for those interested. Notably, there are diverse roles and career paths within research, clinical trials, patient care, and academic sectors for those with the required qualifications and skills. Aspiring professionals may choose to further their studies in this field or related specializations. Those who aspire to participate in path-breaking research or wish to contribute to the academic domain can consider pursuing their education further. One such promising educational avenue can be found at online nursing schools in best online nursing programs in Minnesota. These programs are designed to equip students with a robust study of Oncology, giving emphasis to areas like Prostate cancer, Internal medicine, and other major fields linked with Urology Oncology. Moreover, prospective professionals in this domain need to stay current with the most recent scientific findings and developments, and getting involved in scholarly conferences, seminars, and symposiums can be instrumental. This practice not only helps to keep one updated with the fast-paced advances in Urology Oncology but also provides opportunities to network with other professionals in the field. Lastly, those already working in health sectors, such as nurses and medical consultants, who wish to shift their career focus to Urology Oncology, would find immense opportunities, considering the implications and relevance of this branch of medical science in our society today. Not to mention that certified experts in Urology Oncology have the potential for gratifying earnings, given the demanding nature of their job role. All in all, whether as a research scientist, an academic professor, or a clinical specialist, the field of Urology Oncology presents a myriad of exciting and fulfilling career possibilities to explore.